AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
1.910
-0.070 (-3.54%)
At close: Aug 29, 2025

AccuStem Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
1.381.371.913.480.60.08
Research & Development
0.160.140.140.270.070.01
Operating Expenses
1.541.512.053.750.670.09
Operating Income
-1.54-1.51-2.05-3.75-0.67-0.09
Pretax Income
-1.54-1.51-2.05-3.75-0.67-0.09
Net Income
-1.54-1.51-2.05-3.75-0.67-0.09
Net Income to Common
-1.54-1.51-2.05-3.75-0.67-0.09
Shares Outstanding (Basic)
131111111010
Shares Outstanding (Diluted)
131111111010
Shares Change (YoY)
14.27%0.78%3.00%10.17%--
EPS (Basic)
-0.12-0.13-0.18-0.34-0.07-0.01
EPS (Diluted)
-0.12-0.13-0.18-0.34-0.07-0.01
Free Cash Flow
-0.49-0.66-1.62-1.82--
Free Cash Flow Per Share
-0.04-0.06-0.14-0.17--
EBITDA
-1.54-1.5-2.05-3.74--
D&A For EBITDA
0000--
EBIT
-1.54-1.51-2.05-3.75-0.67-0.09
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.